Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Capabilities Development for Sterile Manufacturing Dr Mauro Giusti, Senior Director, Site External Network at Eli Lilly & President, PDA Italy Chapter Eli Lilly realized that the professionals (chemists, pharmacists, engineers, biologists, biotechnologists, etc) in charge of the Flow Teams and Proces... September 7, 2023 2:00pm Integrity Assurance for Single-Use Systems: End-User Perspective Charlotte Masy at GSK Vaccines and Patrick Evrard at Pall Life Sciences Single-use technologies are more and more used in critical sterile applications, e.g. close to final manufacturing steps handling Drug Product, leadin... 1 year ago | 126 mins Designer Sterile Filtration in Aseptic Processing Using Single Use Technology Alan Kelly, Project Engineer at Sanofi and Terri Love, Senior BioManufacturing at Merck Alan Kelly is a Project Engineer who has been employed within the pharma/biopharma industry in Ireland for the past 25 years and is currently in his 1... 2 years ago | 94 mins Integrity Assurance for SUS: End-User Perspective Charlotte Masy, Project Manager in global support GSK vaccinés and Donald Young, Sr. Product Manager at Thermo Fisher Scienti Single Use technologies are more and more used close to final product leading to increase concern related to integrity. In this article we would like ... 4 years ago | 61 mins A Comprehensive Approach to Assess the Impact of Microbial Impurities on Pat... Dr Friedrich von Wintzingerode, QC Lead iNeST Project at Roche and Shabnam Solati, CEO & Co-Founder at CTL-MAT FULL TITLE: A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics Presented by Dr ... 3 years ago | 80 mins New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical... Presented by Friedrich von Wintzingerode Global QC at Roche Followed by Mathilde Arnault, Research Scientist at Merck KGaA, Full Title: New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process Large scale Production of Biologics is s... 4 years ago | 62 mins
